BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28407149)

  • 21. Simultaneous monitoring of CMV and BKV by quantitative PCR in renal transplant recipients.
    Wu CZ; Chen XQ; Wang ZY; Pan XD; Bai YH; Yang YR; Zheng SL; Xia P
    J Virol Methods; 2014 Dec; 210():40-4. PubMed ID: 25261811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.
    Gentile G; Picardi A; Capobianchi A; Spagnoli A; Cudillo L; Dentamaro T; Tendas A; Cupelli L; Ciotti M; Volpi A; Amadori S; Martino P; de Fabritiis P
    BMC Infect Dis; 2006 Nov; 6():167. PubMed ID: 17118205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.
    Panagou E; Zakout G; Keshani J; Smith C; Irish D; Mackinnon S; Kottaridis P; Fielding A; Griffiths PD
    Transpl Infect Dis; 2016 Jun; 18(3):405-14. PubMed ID: 27061703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait.
    Madi N; Al-Qaser M; Edan R; Al-Nakib W
    Transplant Proc; 2015; 47(6):1802-7. PubMed ID: 26293054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.
    Brytting M; Mousavi-Jazi M; Boström L; Larsson M; Lunderberg J; Ljungman P; Ringdén O; Sundqvist VA
    Transplantation; 1995 Nov; 60(9):961-5. PubMed ID: 7491701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cytomegalovirus pp-65 antigenemia assay and plasma DNA correlation with the clinical outcome in transplant recipients.
    de Oña M; Melón S; Galarraga MC; Palacio A; Lambert JL; Bernardo MJ; Rodríguez M; Gómez E
    Transpl Int; 2005 Jan; 18(1):43-6. PubMed ID: 15612982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
    J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients.
    Sahin DG; Gunduz E; Kasifoglu N; Akay OM; Us T; Gulbas Z
    Adv Ther; 2013 Aug; 30(8):784-91. PubMed ID: 23959787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
    Chen YH; Zhao XS; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang Y; Zhao T; Zhao XT; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1540-3. PubMed ID: 19953881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of cytomegalovirus viral load in renal transplant patients in Argentina.
    Mas V; Alvarellos T; Albano S; de Boccardo G; Giraudo C; Garrett CT; Ferreira-Gonzalez A
    Transplantation; 1999 Apr; 67(7):1050-5. PubMed ID: 10221492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay.
    Furione M; Rognoni V; Cabano E; Baldanti F
    J Clin Virol; 2012 Dec; 55(4):317-22. PubMed ID: 22989927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two quantitative real-time CMV-PCR tests calibrated against the 1st WHO international standard for viral load monitoring of renal transplant patients.
    Mannonen L; Loginov R; Helanterä I; Dumoulin A; Vilchez RA; Cobb B; Hirsch HH; Lautenschlager I
    J Med Virol; 2014 Apr; 86(4):576-84. PubMed ID: 24026892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of real time-polymerase chain reaction in determining cytomegalovirus viral DNA load in renal transplant recipients.
    Zhang CB; Lai HY; Xu HT; Wang DG; Xiao F
    Chin Med J (Engl); 2012 Oct; 125(19):3575-7. PubMed ID: 23044327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Establishment of a real-time PCR assay for simultaneously detecting human BKV and CMV DNA and its application in renal transplantation recipients].
    Zhang CW; Chen XQ; Bai YH; Pan XD; Wang SL; Cai Y; Xia P; Wu CZ; Chen BC
    Bing Du Xue Bao; 2013 Jun; 29(4):410-4. PubMed ID: 23895006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment.
    Bauer CC; Jaksch P; Aberle SW; Haber H; Lang G; Klepetko W; Hofmann H; Puchhammer-Stöckl E
    J Clin Microbiol; 2007 Feb; 45(2):324-8. PubMed ID: 17151208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.